Menu

Blog

Jan 15, 2024

Hodgkin lymphoma prognosis, biology tracked with circulating tumor DNA

Posted by in category: biotech/medical

Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.

Comments are closed.